Conversely, the impact of risankizumab on IFN-γ (another inflammatory cytokine induced downstream of IL-23) was limited, as the activation score (z = −1.97) did not reach statistical significance (z < −2.0).
← all excerpts
Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade.
1
—
—